NCT00100802View on ClinicalTrials.gov

Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas

PHASE2CompletedINTERVENTIONAL

Enrollment

118

Participants

Timeline

Start Date

March 21, 2005

Primary Completion Date

September 1, 2012

Study Completion Date

June 30, 2017

Conditions

Anaplastic AstrocytomaCentral Nervous System NeoplasmGlioblastomaGliosarcomaSpinal Cord Neoplasm

Interventions

OTHER

Laboratory Biomarker Analysis

Correlative studies

DRUG

Lomustine

Given PO

RADIATION

Radiation Therapy

Undergo radiation therapy

DRUG

Temozolomide

Given PO

Trial Locations (1)

19104

Children's Oncology Group, Philadelphia

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT00100802 - Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas | Biotech Hunter | Biotech Hunter